Analysts Set ViewRay, Inc. (VRAY) PT at $10.00
ViewRay, Inc. (NASDAQ:VRAY) has earned a consensus rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation and five have issued a buy recommendation on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $10.00.
A number of equities research analysts have weighed in on VRAY shares. Aegis reissued a “buy” rating and set a $11.00 target price on shares of ViewRay in a report on Saturday, July 22nd. Mizuho started coverage on shares of ViewRay in a report on Wednesday, September 6th. They set a “buy” rating and a $12.00 target price on the stock. Finally, ValuEngine lowered shares of ViewRay from a “hold” rating to a “sell” rating in a report on Friday, September 22nd.
Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of ViewRay by 67.0% during the 2nd quarter. Vanguard Group Inc. now owns 1,026,880 shares of the company’s stock valued at $6,644,000 after acquiring an additional 411,866 shares during the period. State Street Corp lifted its position in shares of ViewRay by 631.7% during the 2nd quarter. State Street Corp now owns 395,418 shares of the company’s stock valued at $2,555,000 after acquiring an additional 341,376 shares during the period. TIAA CREF Investment Management LLC lifted its position in shares of ViewRay by 2,447.3% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 286,365 shares of the company’s stock valued at $1,853,000 after acquiring an additional 275,123 shares during the period. Russell Investments Group Ltd. acquired a new position in shares of ViewRay during the 2nd quarter valued at $1,361,000. Finally, EAM Investors LLC lifted its position in shares of ViewRay by 7.0% during the 2nd quarter. EAM Investors LLC now owns 202,713 shares of the company’s stock valued at $1,312,000 after acquiring an additional 13,243 shares during the period. Hedge funds and other institutional investors own 53.70% of the company’s stock.
Shares of ViewRay (NASDAQ VRAY) traded up $1.10 during trading on Thursday, hitting $8.31. 2,395,886 shares of the company traded hands, compared to its average volume of 724,363. The company has a debt-to-equity ratio of -2.62, a quick ratio of 1.45 and a current ratio of 1.73. ViewRay has a 12 month low of $2.67 and a 12 month high of $10.39.
ViewRay (NASDAQ:VRAY) last announced its quarterly earnings results on Monday, August 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.02). The company had revenue of $0.70 million for the quarter, compared to the consensus estimate of $0.68 million. The company’s revenue was up 133.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.32) earnings per share. equities research analysts forecast that ViewRay will post -0.81 EPS for the current year.
ViewRay Company Profile
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
Receive News & Ratings for ViewRay Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ViewRay Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.